Immunomodulatory activity of Lactobacillus plantarum KLDS1.0318 in cyclophosphamide-treated mice

  • Yueyue Meng
  • Bailiang Li
  • Da Jin
  • Meng Zhan
  • Jingjing Lu
  • Guicheng Huo
Keywords: Lactobacillus plantarum KLDS1, 0318, splenocyte proliferation, NK cell activity, macrophages phagocytosis, cytokine


Background: Probiotics in fermented foods have attracted considerable attention lately as treatment options for immune diseases, the incidence of which has been increasing throughout the world.

Objective: The objective of the present study was to investigate the immunomodulatory activity of Lactobacillus plantarum (L. plantarum) KLDS1.0318 in cyclophosphamide-treated mice.

Design: To investigate the immune-enhancing effects of L. plantarum KLDS1.0318, we used a immunosuppressive model. Ninety female six-week-old BALB/c mice were randomly divided into six groups: normal control (NC) group, model control (MC) group, immunosuppression plus L. plantarum KLDS1.0318 groups with three different doses (KLDS1.0318-L, KLDS1.0318-M, and KLDS1.0318-H), and plus levamisole hydrochloride as positive control (PC) group.

Results and discussions: Results showed that the thymus and spleen indexes of the four treatment groups were significantly higher than those of the MC group (2.01±0.16) ( p < 0.05). The capacity of lymphocyte proliferation, the activity of natural killer (NK) cell and macrophages phagocytosis were significantly increased ( p < 0.05) in four treatment groups as compared with the MC group (0.327±0.022, 62.29±0.8, 0.087±0.008, respectively). The levels of relative immune factors (IL-2, IL-6, and IFN-γ) showed similar patterns ( p < 0.05).

Conclusions: This study suggested that orally administered L.plantarum KLDS1.0318 may effectively accelerate the recovery of immunosuppressive mice caused by cyclophosphamide (CTX). The immunomodulatory activity of the srtain recommended that L. plantarum KLDS1.0318 could be used as a powerful medicinal treatment against immunosuppression.


Download data is not yet available.


  1. Yan ZG, Du YJ, Zhao QY, Fan RF, Guo WL, & Ma RD, et al. Mucosal immune responses against live Newcastle disease vaccine in immunosuppressed chickens. Pak Vet J 2011; 31(4): 280–6.

  2. Cui ZZ, Meng SS, Jiang SJ, Wei JP. Serological surveys zof chicken anemia virus, avian reticuloendotheliosis virus and avian reovirus infections in white meat-type chickens in China. Acta Veterinaria Et Zootechnica Sinica 2006; 37(2): 152–7.

  3. Cazaban C. Immunosuppression in chickens – what is it? Int Poul Prod 2006; 13(8): 13–14

  4. Shini S, Shini A, Kaiser P. Cytokine and chemokine gene expression profiles in heterophils from chickens treated with corticosterone. Stress 2010; 13(3): 185–94.

  5. Patel DM, Riedel DJ. Fever in immunocompromised hosts. Emerg Med Clin North Am 2013; 31(4): 1059.

  6. Bagga A, Hari P. Levamisole-induced vasculitis. Pediatr Nephrol 2000; 14(10–11): 1057.

  7. Joly C, Palisse M, Ribbe D, De CO, & Genevey P. [Acute levamisole poisoning]. Presse Medicale 1998; 27(15): 717.

  8. Palcoux JB, Niaudet P, Goumy P. Side effects of levamisole in children with nephrosis. Pediatr Nephrol 1994; 8(2): 263.

  9. Fan Y, Lu Y, Wang D, Liu J, Song X, Zhang W, et al. Effect of epimedium polysaccharide-propolis flavone immunopotentiator on immunosuppression induced by cyclophosphamide in chickens. Cell Immunol 2013; 281(1): 37–43.

  10. de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 2008; 111(8): 1.

  11. Goldin BR. Health benefits of probiotics. Br J Nutr 1998; 80(4): S203.

  12. Galdeano C, Perdigon G. Role of viability of probiotic strains in their persistence in the gut and in mucosal immune stimulation. J Appl Microbiol 2004; 97(4): 673.

  13. Paturi G, Phillips M, Jones M, & Kailasapathy K. Immune enhancing effects of Lactobacillus acidophilus LAFTI L10 and Lactobacillus paracasei LAFTI L26 in mice. Int J Food Microbiol 2007; 115(1): 115–118.

  14. Cross ML. Microbes versus microbes: immune signals generated by probiotic lactobacilli and their role in protection against microbial pathogens. Fems Immunol Med Microbiol 2002; 34(4): 245–53.

  15. Gill HS, Rutherfurd KJ, Prasad J, Gopal PK. Enhancement of natural and acquired immunity by Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019). Br J Nutr 2000; 83(2): 167–76.

  16. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 2001; 74(6): 833.

  17. Kirjavainen PV, EI-Nezami HS, Salminen SJ, Ahokas JT, Wright PF, et al. The effect of orally administered viable probiotic and dairy lactobacilli on mouse lymphocyte proliferation. Fems Immunol Med Microbiol 1999; 26(2): 131–5.

  18. Nagafuchi S, Takahashi T, Yajima T, Kuwata T, Hirayama K, Itoh K, et al. Strain dependency of the immunopotentiating activity of Lactobacillus delbrueckii subsp. bulgaricus. Biosci Biotechnol Biochem 1999; 63(3): 474.

  19. Kawashima T, Hayashi K, Kosaka A, Kawashima M, Igarashi T, Tsutsui H, et al. Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responses. Int Immunopharmacol 2011; 11(12): 2017–24.

  20. Kikuchi Y, Kunitoh-Asari A, Hayakawa K, Imai S, Kasuya K, Abe K, Adachi Y, Fukudome S, Takahashi Y, Hachimura S. 2014. Oral administration of Lactobacillus plantarum strain AYA enhances IgA secretion and provides survival protection against influenza virus infection in mice. PLoS One 9, e86416.

  21. Rigaux P, Daniel C, Hisbergues M, Muraille E, Hols P, Pot B, et al. Immunomodulatory properties of Lactobacillus plantarum, and its use as a recombinant vaccine against mite allergy. Allergy 2009; 64(3): 406–14.

  22. Rizzo A, Losacco A, Carratelli CR, Domenico MD, Bevilacqua, N. Lactobacillus plantarum reduces Streptococcus pyogenes virulence by modulating the IL-17, IL-23 and Toll-like receptor 2/4 expressions in human epithelial cells. Int Immunopharmacol 2013; 17(2): 453–61.

  23. Yueyue M, Li Z, Guicheng H. Effects of ten strains of Lactobacillus on the activity of immune cells in vitro. Sci Technol Food Ind (in Chinese), 2018; 39(01): 312–317.

  24. Jimenez M. Modification of mitogen-driven lymphoproliferation by ceftriaxone in normal and immunocompromised mice. Int J Antimicrob Agents 2003; 22(6): 607.

  25. Guo Y, Pan D, Li H, Sun Y, Zeng X, Yan B. Antioxidant and immunomodulatory activity of selenium exopolysaccharide produced by Lactococcus lactis subsp. lactis. Food Chem 2013; 138(1): 84–9.

  26. Grønbaek H, Skjaerbaek C, Orskov H, Flyvbjerg A. Effect of immunosuppression on kidney and serum insulin-like growth factor-I (IGF-I), IGF binding proteins, and renal growth following unilateral nephrectomy in rats. Metab Clin Exp 1998; 47(7): 817–23.

  27. Xu C, Wang Y, Jin M, Yang X. Preparation, characterization and immunomodulatory activity of selenium-enriched exopolysaccharide produced by bacterium Enterobacter cloacae Z0206. Bioresour Technol 2009; 100(6): 2095–7.

  28. Yuan H, Song J, Li X, Li N, Dai J. Immunomodulation and antitumor activity of κ-carrageenan oligosaccharides. Cancer Lett 2006; 243(2): 228–34.

  29. Yuan C, Wang C, Bu Y, Xiang T, Huang X, Wang Z, et al. Antioxidative and immunoprotective effects of Pyracantha fortuneana (Maxim.) Li polysaccharides in mice. Immunol Lett 2010; 133(1): 14–18.

  30. Ren D, Li C, Qin Y, Yin R, Du S, Liu H, et al. Evaluation of immunomodulatory activity of two potential probiotic Lactobacillus strains by in vivo tests. Anaerobe 2015; 35(Pt B): 22–7.

  31. Park YJ, Liu G, Tsuruta Y, Lorne E, Abraham E. Participation of the urokinase receptor in neutrophil efferocytosis. Blood 2009; 114(4): 860.

  32. Wang H, Wang M, Chen J, Tang Y, Dou J, Yu J, et al. A polysaccharide from Strongylocentrotus nudus eggs protects against myelosuppression and immunosuppression in cyclophosphamide-treated mice. Int Immunopharmacol 2011; 11(11): 1946.

  33. Yu X, Wang C, Luo J, Zhao X, Wang L, Li X. Combination with methotrexate and cyclophosphamide attenuated maturation of dendritic cells: inducing Treg Skewing and Th17 suppression in vivo. Clin Dev Immunol 2014; 2013(1): 238035.

  34. Yu Q, Nie SP, Wang JQ, Liu XZ, Yin PF, Huang DF, et al. Chemoprotective effects of Ganoderma atrum polysaccharide in cyclophosphamide-induced mice. Int J Biol Macromol 2014; 64: 395–401.

  35. Elmadfa I, Klein P, Meyer AL. Immune-stimulating effects of lactic acid bacteria in vivo and in vitro. Proc Nutr Soc 2010; 69(3): 416.

  36. Masood MI, Qadir MI, Shirazi JH, Khan IU, et al. Beneficial effects of lactic acid bacteria on human beings. Crit Rev Microbiol 2011; 37(1): 91.

  37. Won TJ, Kim B, Oh ES, Bang JS, Lee YJ, Yoo JS, et al. Immunomodulatory activity of Lactobacillus strains isolated from fermented vegetables and infant stool. Can J Physiol Pharmacol 2011; 89(6): 429.

  38. Nakamura S, Kuda T, An C, Kanno T, Takahashi H, Kimura B. Inhibitory effects of Leuconostoc mesenteroides 1RM3 isolated from narezushi, a fermented fish with rice, on Listeria monocytogenes infection to Caco-2 cells and A/J mice. Anaerobe 2012; 18(1): 19–24.

  39. Li CY, Lin HC, Lai CH, Lu JJ, Wu SF, Fang SH. Immunomodulatory effects of lactobacillus and Bifidobacterium on both murine and human mitogen-activated T cells. Int Arch Allergy Immunol 2011; 156(2): 128–36.

  40. Li SP, Zhao XJ, Wang JY. Synergy of Astragalus polysaccharides and probiotics (Lactobacillus and Bacillus cereus) on immunity and intestinal microbiota in chicks. Poult Sci 2009; 88(3): 519–25.

  41. Campbell C, Chew B, Luedecke L, Shultz T. Yogurt consumption does not enhance immune function in healthy premenopausal women. Nutrition & Cancer-an International Journal 2000; 37(1): 27–35.

  42. Son EH, Moon EY, Rhee DK, Pyo S. Stimulation of various functions in murine peritoneal macrophages by high mannuronic acid-containing alginate (HMA) exposure in vivo. Int Immunopharmacol 2001; 1(1): 147.

  43. Hoover SK, Barrett SK, Turk TMT, Lee TC, Bear HD, Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity. Cancer Immunol Immunother 1990; 31(2): 121–7.

  44. Salgame P, Abrams JS, Clayberger C, Goldstein H, Convit J, Modlin RL, et al. Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 1991; 254(5029): 279.

  45. Sobota RM, Muller PJ, Khouri C, Ullrich A, Poli V, Noguchi T, et al. SHPS-1/SIRP1 alpha contributes to interleukin-6 signalling. Cell Signal 2008; 20(7): 1385–1391.

  46. Letsch A, Scheibenbogen C. Quantification and characterization of specific T-cells by antigen-specific cytokine production using ELISPOT assay or intracellular cytokine staining. Methods 2003; 31(2): 143–9.

  47. Sugisaki H, Yamanaka K, Kakeda M, Kitagawa H, Tanaka K, Watanabe K, et al. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. J Dermatol Sci 2009; 55(1): 47–52.

  48. Jang SE, Joh EH, Ahn YT, Huh CS, Han MJ, Kim DH. Lactobacillus casei HY7213 ameliorates cyclophosphamide-induced immunosuppression in mice by activating NK, cytotoxic T cells and macrophages. Immunopharmacol Immunotoxicol 2013; 35(3): 396–402.

How to Cite
Meng Y, Li B, Jin D, Zhan M, Lu J, Huo G. Immunomodulatory activity of <em>Lactobacillus plantarum</em&gt; KLDS1.0318 in cyclophosphamide-treated mice. Food & Nutrition Research [Internet]. 21Mar.2018 [cited 22Sep.2018];62. Available from:
Original Articles